Alvydas Mikulskis

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

Jeff Sevigny, Ping Chiao, Thierry Bussière et al. · Nature · 2016 · 3K citations

Neurodegenerative Diseases, Alzheimer's Disease, Medicine +7

First‐in‐human, double‐blind, placebo‐controlled, single‐dose escalation study of aducanumab (BIIB037) in mild‐to‐moderate Alzheimer's disease

J L Ferrero, Leslie Williams, Heather Stella et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2016 · 176 citations · Full text

Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment

Shorena Janelidze, Josef Pannee, Alvydas Mikulskis et al. · JAMA Neurology · 2017 · 139 citations · Full text

High-Resolution Serum Proteomic Profiling of Alzheimer Disease Samples Reveals Disease-Specific, Carrier-Protein–Bound Mass Signatures

Mary F. Lopez, Alvydas Mikulskis, Scott Kuzdzal et al. · Clinical Chemistry · 2005 · 138 citations · Full text

A Novel, High-Throughput Workflow for Discovery and Identification of Serum Carrier Protein-Bound Peptide Biomarker Candidates in Ovarian Cancer Samples

Mary F. Lopez, Alvydas Mikulskis, Scott Kuzdzal et al. · Clinical Chemistry · 2007 · 112 citations